Guidance for industry : ANDAs, impurities in drug substances.
Corporate Author: | Center for Drug Evaluation and Research (U.S.). Office of Generic Drugs |
---|---|
Format: | Government Document eBook |
Language: | English |
Published: |
Rockville, MD :
U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,
[2009]
|
Subjects: | |
Online Access: | https://purl.fdlp.gov/GPO/LPS117047 |